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Malaria is a major health burden in tropical and subtropical countries. The antimalarial drug primaquine
is extremely useful for killing the transmissible gametocyte forms of Plasmodium falciparum and the
hepatic quiescent forms of P. vivax. Yet its mechanism of action is still poorly understood. In this study,
we used the yeast Saccharomyces cerevisiae model to help uncover the mode of action of primaquine. We
found that the growth inhibitory effect of primaquine was restricted to cells that relied on respiratory
function to proliferate and that deletion of SOD2 encoding the mitochondrial superoxide dismutase se-
verely increased its effect, which can be countered by the overexpression of AIM32 and MCR1 encoding
mitochondrial enzymes involved in the response to oxidative stress. This indicated that ROS produced by
respiratory activity had a key role in primaquine-induced growth defect. We observed that Δsod2 cells
treated with primaquine displayed a severely decreased activity of aconitase that contains a Fe–S cluster
notoriously sensitive to oxidative damage. We also showed that in vitro exposure to primaquine impaired
the activity of puriﬁed aconitase and accelerated the turnover of the Fe–S cluster of the essential protein
Rli1. It is suggested that ROS-labile Fe–S groups are the primary targets of primaquine. Aconitase activity
is known to be essential at certain life-cycle stages of the malaria parasite. Thus primaquine-induced
damage of its labile Fe–S cluster – and of other ROS-sensitive enzymes – could inhibit parasite devel-
opment.
& 2015 Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Malaria is a mosquito borne infectious disease that causes ﬂu-
like symptoms and can lead to organ failure and death. In 2013, an
estimated 198 million cases of malaria were registered by the
World Health Organisation (WHO, 2014).
The disease is caused by a unicellular eukaryotic parasite of the
genus Plasmodium. Among the ﬁve species known to infect hu-
mans, P. falciparum is the most dangerous and P. falciparum and P.
vivax are the most frequently encountered worldwide. Plasmodium
parasites have a complex life cycle during which they adopt dif-
ferent forms [1]. In the context of malaria control and elimination,n open access article under the CC
.fr (B. Meunier).
iophysics, Utrecht University,an increasing effort is focused on the transmissible blood stage
forms of the parasite known as gametocytes and on the quiescent
liver stage forms of P. vivax and P. ovale that cause relapses, known
as hypnozoites. Targeting these parasite reservoirs currently relies
solely on drugs. Primaquine is the only approved drug effective
against hypnozoites and is also an efﬁcient transmission-blocking
agent through its gametocytocide activity (for review [2]).
Primaquine (PQ)1 is an 8-aminoquinoline developed in the
1940's that displays antimalarial activity at low micromolar con-
centrations against hypnozoites [3] and gametocytes [4–6]. De-
spite this remarkable activity, its precise mechanism of action is
still poorly understood. Ultrastructural and functional studies
suggest that PQ treatment affects the parasite mitochondrion [7–
10]. In humans, PQ is transformed into several metabolites mainly
by the cytochrome P450 (CYP450) 2D6 and by the monoamine
oxidase A [11]. Some PQ phenolic metabolites have been described
to be the active compounds against Plasmodium parasites and areBY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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PQ was also shown to induce oxidative stress in mammalian cells
[15,16]. In addition, PQ treatment provokes severe side effects in
people deﬁcient in erythrocytic enzymes controlling oxidative
stress, such as the glucose-6-phosphate dehydrogenase (G6PD)
and the NADH-methemoglobin reductase [17,18].
Here we explored the mechanism of action of PQ in the yeast S.
cerevisiae. Yeast has well-known advantages for such studies,
providing valuable genetic and biochemical tools. Deletion of non-
essential genes is straightforward and collections of deletion mu-
tants are available. In addition, yeast can survive in the absence of
respiration by using the fermentation process as an energy source.
Therefore the detrimental effect of a compound, such as PQ, can be
tested in cells lacking enzymes involved in antioxidant defence
with or without active respiratory function. Using this approach,
we identiﬁed genes involved in PQ sensitivity. The data support
key roles for oxidative damage and respiratory function in the
action of PQ. We then tested the consequence of PQ exposure on
Fe–S cluster containing enzymes known to be susceptible to oxi-
dative damage.
1 List of abbreviations: PQ, primaquine; SOD, superoxide dis-
mutase; SO, superoxide; ROS, reactive oxygen species; OD, optical
density; wt, wildtype strain; Fe–S, Iron–Sulphur.2. Materials and methods
2.1. Chemicals
Primaquine, sodium L-ascorbate, DL-isocitric acid, L-malic acid,
n-acetyl-L-cysteine, mitochondrial aconitase from porcine heart
and cis-aconitate were purchased from Sigma Aldrich.
2.2. S. cerevisiae strains and culture media
S. cerevisiae strains from the series BY4742 (MATα; his3Δ;
leu2Δ; lys2Δ; ura3Δ), including this wt (wildtype) and derived
isogenic deletion strains, were from Euroscarf (Frankfurt, Ger-
many). The wt strain CWWT (MATα ade2-1 his3- leu2-3,112 trp1-1
ura3-1) is derived from W303-1B.
The following growth media were used: YPD (1% yeast extract,
2% peptone, 2% glucose), YPEth (1% yeast extract, 2% peptone, 2%
ethanol), YPG (1% yeast extract, 2% peptone, 3% glycerol), YPGal
(1% yeast extract, 2% peptone, 0.2% glucose, 2% galactose), YP10 (1%
yeast extract, 2% peptone, 10% glucose), and CSM (0.7% yeast ni-
trogen base, 2% glucose, 2% agar and 0.8 g/l of a complete sup-
plement mixture minus uracil or minus leucine, supplied by Bio
101 (san Diego, CA, USA)).
2.3. Primaquine sensitivity test
PQ sensitivity was assessed by monitoring the inhibition of
yeast cell proliferation. Yeasts were grown in 5 ml culture medium
with increasing concentrations of primaquine. Cultures were in-
oculated from two-day-old cultures on YPG to an OD600 nm of
0.1 and incubated at 28 °C. Cell density measured as OD600 nm was
estimated when the control cultures had reached stationary phase,
one or three days after inoculation, depending on the culture
medium. PQ sensitivity is presented for each strain and culture
condition as the percentage of growth relative to control, i.e. un-
treated by PQ.
2.4. Generation of rho° mutants
Rho° mutants (devoid of mitochondrial DNA) were generated
by growing cells on YPD medium containing 40 g/L of ethidiumbromide for three rounds of culture.
2.5. Assessment of rho or rho° production
The mutant Δsod2 was grown in YPD at 1 mM PQ. Three
rounds of 24 h culture were performed. Cells were then diluted
and spread on YPD plates to obtain approx. 200 cells per plate.
After three days growth, the colonies were replica-plated to YPG
agar. The number of colonies able to grow on this respiratory
medium was recorded. This was compared to data obtained with
untreated cultures.
2.6. Isolation of multicopy suppressors of primaquine sensitivity
The PQ-sensitive Δsod2 mutant was transformed with a high-
copy wild type genomic library made in the URA3 2μ vector
pFL44L [19]. Approximatively 20,000 Uraþ clones were selected
and replica-plated onto YPG containing 500 mM PQ. Clones with
increased resistance to PQ appearing after 4–5 days were analysed.
The plasmid-borne resistance to PQ was rechecked. The chromo-
somal fragments present on the plasmids were then identiﬁed by
sequencing.
2.7. Gene cloning on high copy number plasmid for gene over-
expression
SOD2, MCR1, SOD1 and LYS7 genes with their own promoter
region were cloned in the multicopy vector pFL44-URA3 (SOD2
and MCR1), YEp352-URA3 (SOD1) or YEp351-LEU2 (LYS7). The
fragment encompassing the SOD2 gene (open reading frame (ORF)
and native promoter) was digested with BamHI and XmaI enzymes
from a vector isolated from the high copy number library con-
taining the SOD2 gene and then ligated between the BamHI-XmaI
sites of the pFL44 vector. Fragments encompassing the SOD1 and
LYS7 genes were digested with EcoRI and XbaI enzymes (SOD1) or
SalI and SacI enzymes (LYS7) from the pRS405-SOD1 vector and
pRS403-LYS7 vectors respectively. Those two vectors were kindly
supplied by P. Piper, University of Shefﬁeld, UK. The fragments
were then ligated between the corresponding sites in the relevant
destination vectors (see above). The MCR1 gene fragment was
ampliﬁed from yeast genomic DNA with the SalI_MCR1_F (CAT-
AGTCGACAATGCAAACTCTCCCACCAG) and MCR1_R (CTGCCAA-
GAAGACGTTGGTT) primers, digested with SalI and SphI enzymes
and then ligated between the SalI-SphI sites of the pFL44 vector.
2.8. Aconitase and fumarase measurement using cell extracts
The aconitase and fumarase activities were determined spec-
trophotometrically by monitoring the formation of cis-aconitate
and fumarate at 240 nm and 25 °C [20–22]. Brieﬂy, cell extracts
were prepared from 2.0108 cells (OD600 20) grown on YPGal.
Lysis was performed at 4 °C in 10 mM MES buffer, pH6 containing
0.6 mM MnCl2 and deprived of oxygen (by bubbling with nitrogen
gas) with 0.5 mm glass beads (v/v), by vortexing for 30 s followed
by incubation on ice for 30 s, repeating the process seven times.
Cell debris were removed by centrifugation at 13,000 rpm for
5 min, and the resulting supernatant was aliquoted and frozen
immediately in liquid nitrogen and kept at 80 °C (for a max-
imum of one month). Samples were thawed just before the assay
[23]. Protein concentration was determined spectro-
photometrically with the Bio-Rad protein assay kit, according to
the manufacturer's instructions.
For the aconitase activity, the assay mixture contained 50 mM
potassium phosphate buffer, pH 7.4, 30 mM sodium isocitrate,
0.6 mM MnCl2, and 150–250 mg of protein for a ﬁnal volume of
1 ml. For the fumarase activity, the assay mixture contained
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and 150–250 mg of protein for a ﬁnal volume of 1 ml. The absor-
bance changes were measured for 5–30 min, and the activity was
calculated from the slope of the linear portion; ε240
¼3.6 mM1 cm1 for cis-aconitate and ε240¼2.44 mM1 cm1
for fumarate.
2.9. bc1 complex and succinate dehydrogenase activity measurement
using puriﬁed mitochondria
Yeast mitochondria were prepared as in [24]. Brieﬂy, yeast cells
grown in YPGal medium were harvested at mid-log phase. Pro-
toplasts were obtained by enzymatic digestion of the cell wall
using zymolyase in an osmotic protection buffer. Mitochondria
were then prepared by differential centrifugation following os-
motic shock of the protoplasts. Mitochondrial samples were ali-
quoted and stored at 80 °C.
The concentration of bc1 complex in the mitochondrial samples
was determined from dithionite-reduced optical spectra, using ε
¼28.5 mM1 cm1 at 562 nm–575 nm. Decylubiquinol-cyto-
chrome c reductase activities were determined at room tempera-
ture by measuring the reduction of cytochrome c (ﬁnal con-
centration of 20 mM) at 550 nm versus 540 nm over a one-minute
time-course in 10 mM potassium phosphate pH 7, 0.01% (w/v)
Lauryl-maltoside and 1 mM KCN. Mitochondria were added to
obtain a ﬁnal concentration of 4 to 10 nM bc1 complex. Activity
was initiated by the addition of 40 μM decylubiquinol. The mea-
surements were repeated three to ﬁve times and averaged.
Succinate cytochrome c reductase activity was assessed by
measuring the reduction of cytochrome c as described for bc1
complex activity. With the exception that the activity was initiated
by the addition of 10 mM succinate in a 50 mM phosphate buffer
without Lauryl-maltoside. Mitochondria were added to obtain a
ﬁnal concentration of 20 to 30 nM bc1 complex.
2.10. Oxygen uptake measurements with intact cells
Oxygen consumption rates were measured in a stirred reaction
vessel of a Clark-type O2 electrode at 25 °C. Whole cells oxygen
uptake assays were carried out using around 108 cells mL1
(grown in YPGal) in fresh YPGal medium with and without 3 μM
CCCP (carbonyl cyanide m-chlorophenylhydrazone). After 2–3 min
recording, PQ was added at various concentrations and the rate of
oxygen consumption was recorded.
2.11. Aconitase measurement using porcine mitochondrial aconitase
100 mg of mitochondrial aconitase from porcine heart (Sigma)
was dissolved in 25 mM Hepes pH 7.8 and loaded on a HiScreen
Capto Q ImpRes column (GE Healthcare). Proteins were eluted
with a linear NaCl gradient (0–1 M). Fractions containing aconitase
were pooled and concentrated on a Vivaspin 30 K concentrator
(Sartorius). Aconitase was reactivated by incubation for 1 h at
room temperature under anaerobic conditions in a glove box (Ja-
comex, O2o9 ppm) with 5X_Mohr's salt and Na2S and loaded on a
NAP-5 gel ﬁltration column (GE Healthcare) equilibrated with
25 mM Hepes (pH 7.8) and 100 mM NaCl. Aconitase activity was
measured in degazed 100 mM Tris–HCl pH 7.4 0.4 mM sodium
citrate at 37 °C. The absorbance changes were measured for
15 min, and the activity was calculated from the slope of the linear
portion using ε240¼3.6 mM1 cm1. The speciﬁc activity of pur-
iﬁed mitochondrial aconitase was of 2500 u μg1.
2.12. 55Fe-labelling and Fe-S cluster turnover in Rli1
For in vitro analysis of iron turnover, 200 ml culture (BY4741transformed with high-copy tet bearing plasmid (pCM190) over-
expressing HA-tagged Rli1) [25] that had been pre-incubated for
3 h with 55FeCl3 (36 mCi) (Perkin-Elmer) was harvested by cen-
trifugation (1500g, 5 min). Cells were washed and resuspended in
lysis buffer (400 ml oxygen-free 50 mM phosphate buffer, pH 7.4,
3% (v/v) glycerol, 5 mM PMSF (Sigma-Aldrich, St. Louis, MO),
EDTA-free protease inhibitor cocktail (Roche, Indianapolis, IN))
together with 500 ml of glass beads, diameter 425–600 μm. Sam-
ples were vortexed at maximum speed three times for 1 min, in-
terspersed with three 1-min cooling periods on ice, before cen-
trifugation at 16,000g for 5 min. Protein in the supernatant was
determined with a Bradford assay kit (Bio-Rad, Hercules, CA).
Protein (∼500 ml) was mixed with 80 ml anti-HA beads (A2095;
Sigma-Aldrich) for 1 h at 4 °C. Beads were washed four times with
lysis buffer. Aliquots of the beads were incubated aerobically for
10 min at room temperature with 350 mM sodium L-ascorbate and
100 mM histidine [25,26] in the absence or presence of primaquine.
Beads were collected by centrifugation, suspended in 5 ml scin-
tillation ﬂuid (Emulsiﬁer Safe; Perkin Elmer-Cetus, Waltham, MA),
and bead-associated 55Fe measured with a Packard Tri-Carb
2100TR liquid scintillation analyzer (Meriden, CT).3. Results
3.1. Primaquine inhibits yeast respiratory growth
Yeast can use both respiratory function and fermentation to
produce energy. With ethanol or glycerol as carbon source (YPEth
and YPG media) the cells exclusively rely on respiratory function to
generate energy and thus to proliferate. With glucose or galactose
as carbon source (YPGal and YPD media) and vigorous aeration,
cells use both respiration and fermentation. Yeast use fermentation
only in high glucose (YP10 medium) and low oxygen (without
aeration) conditions. Rho° mutants that lack the mitochondrial
genome and thus respiratory chain enzymes grow exclusively by
fermentation in YPD or YPGal medium with vigorous aeration. By
comparing drug effects on yeast growth in these culture conditions,
the role of respiratory function in drug action could be assessed.
We ﬁrst tested the effect of PQ on the respiratory growth of the
wt strain CWWT. The strain was cultivated in YPEth medium with
and without primaquine (PQ). Cultures were inoculated at an
OD600 nm of 0.1 and incubated at 28 °C with vigorous aeration. In
parallel, the effect on fermentative growth was monitored. The
CWWT strain was grown in YP10 medium without aeration with
or without 2 mM PQ, and a rho° mutant derived from CWWT was
cultured in YPGal medium with vigorous aeration with and
without 2 mM PQ.
Cell densities were measured as OD600 nm when the cultures
reached the stationary phase. The data are presented as percen-
tage of growth relative to control, i.e. untreated by PQ (Fig. 1A). At
2 mM PQ, respiratory growth was severely inhibited but not fer-
mentative growth.
3.2. Sod2 deﬁciency increases the inhibitory effect of primaquine on
yeast respiratory growth
As PQ was reported to induce oxidative stress in eukaryotic
cells [15,16], and to interfere with mitochondrial ultrastructure
and function in Plasmodium cells [7–10], we checked the inhibitory
effect of PQ on the respiratory growth of a series of mutants with
deletions of genes involved in oxidative stress defence (17 genes),
in mitochondrial and/or nuclear DNA repair (three genes), in the
mitochondrial respiratory chain (six genes), or in mitochondrial
membrane organisation (one gene). The genes tested and the role
and subcellular localisation of the gene products are listed in Table
Fig. 1. Inhibitory effect of primaquine on yeast growth. Yeast wt and mutant strains were grown in different culture media in the absence or presence of PQ. Cells from a two-
day-old culture on YPG agar were inoculated to an OD600 nm of 0.1 in 5 ml. Cell densities (OD600 nm) were estimated after one to three days growth. The data are presented
as percentages of the culture OD600 nm without PQ. The measurements were repeated two to eight times and the data averaged. Error bars represent the standard
deviation. A. Effect of primaquine on respiratory and fermentative growth. The CWWT strain was grown in YPEth with vigorous aeration (blue) and in YP10 without aeration
(light grey). A rho° mutant derived from CWWT was cultured in YPGal with vigorous aeration (dark grey). B. Effect of gene deletion on primaquine sensitivity. Wt BY4742
(blue), Δccp1 (orange), Δsod1 (purple) and Δsod2 (magenta) strains were grown in YPEth in the absence or presence of 0.2 and 0.5 mM PQ with vigorous shaking for
aeration. C. Effect of primaquine on respiratory and fermentation growth of Δsod2 cells. The cultures were supplemented with 1 mM PQ. Δsod2 was grown in YPEth
(magenta), in YP10 without aeration (magenta), in YPGal (magenta) and in YPGal plus 0.4 μM azoxystrobin (light grey), with vigorous aeration. A rho° mutant derived from
Δsod2 was cultured in YPGal with vigorous aeration (dark grey). Its control wt strain BY4742 was grown in YPEth (blue).
Fig. 2. Effect of ascorbate and N-acetyl cysteine, and of the over-expression of
SOD2, AIM32 and MCR1 on primaquine susceptibility of the Δsod2 mutant. Cells
from a two-day-old culture on YPG agar were inoculated to an OD600 nm of 0.1 in
5 ml of YPEth or YPG with or without PQ. Ascorbate (Asc) or N-acetyl cysteine
(NAC) were added at a concentration of 5 mM. The cultures were incubated at 28 °C
with vigorous shaking for aeration. Cell densities were estimated after three days.
The sensitivity to PQ is presented for each condition or strain as the percentage of
growth relative to the control, i.e. OD600 nm without PQ. Values represent the
averages of two or three independent cultures, with error bars representing stan-
dard deviation. Δsod2 grown in YPEth with 0.2 mM primaquine with or without
Asc or NAC (blue); Δsod2 and Δsod2 overexpressing SOD2, AIM32 orMCR1 grown in
YPEth with 0.3 mM primaquine (magenta); Δsod2 and Δsod2 overexpressing SOD2,
AIM32 or MCR1 grown in YPG with 0.1 mM primaquine (brown).
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letion mutants were cultured in the presence or absence of PQ and
the cell density (estimated by the OD at 600 nm) was measured
after three days of incubation at 28 °C with vigorous shaking for
good aeration. A ﬁrst screen was performed in YPG medium
(supplemental Fig. S1) and the data conﬁrmed by monitoring the
growth in YPEth medium, as illustrated in Fig. 1B. Of the 27 mu-
tants tested, only two mutants clearly displayed an increased
susceptibility to PQ: Δsod2, lacking the mitochondrial superoxide
dismutase and Δsod1, lacking the mainly cytosolic superoxide
dismutase. The Δsod2 mutant showed a more severe sensitivity
than Δsod1.
We then compared the effect of PQ on the respiratory and
fermentative growth of Δsod2. To achieve exclusive respiratory
growth, the strain was cultivated in YPEth with vigorous aeration.
To obtain exclusive fermentation, three culture conditions were
used: Δsod2 grown in YP10 without agitation; Δsod2 cultured in
YPGal with vigorous aeration in the presence of 0.4 μM azoxy-
trobin, which fully and speciﬁcally inhibits respiratory chain
complex III activity; Δsod2 rho°, generated by ethidium bromide
treatment, cultured in YPGal with vigorous aeration.
As shown in Fig. 1C, the Δsod2 mutant growing by fermenta-
tion (YP10, YPGal plus azoxystrobin and rho° mutant in YPGal) was
found to be insensitive to 1 mM PQ, while its respiratory growth
(YPEth) was severely decreased. The respiratory growth of the
parental wt strain BY4742 was not decreased by 1 mM PQ. That
strain was found to be less sensitive to PQ than the CWWT strain.
At 1 and 2 mM PQ, CWWT growth yield reached respectively 50%
and 12% of control yield while, at the same concentrations, BY4742
growth yield reached 100% and 67% of control yield. The Δsod1
mutant displayed a behaviour similar to Δsod2; its PQ sensitivity
was observed only when cells grew by respiration (not shown).
We also monitored the effect of PQ on Δsod2 with an active
respiratory function grown in YPGal with vigorous aeration. Ad-
dition of 1 mM PQ in YPGal (supporting both respiration and fer-
mentation) decreased the growth yield by approximately 50%
while in YPEth (exclusively respiration), PQ had a more severe
effect (Fig. 1C). The increase in PQ sensitivity correlated with in-
creasing reliance on respiration.The results indicated that an active respiratory function is re-
quired for the inhibitory action of PQ onΔsod2 andΔsod1 cells, as
observed with the control strain CWWT.3.3. Chemical and genetic rescue of primaquine sensitivity of Δsod2
In order to get more insight to the inhibitory action of PQ, we
tested possible means to rescue PQ sensitivity during respiratory
growth of Δsod2 cells.
First we checked whether the decreased respiratory growth of
the Δsod2 mutant in the presence of PQ could be rescued by anti-
oxidant agents. As shown in Fig. 2, the addition of 5 mM ascorbate
or n-acetyl cysteine (NAC) to the culture medium largely restored
the growth of Δsod2.
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the PQ sensitivity. To that end, theΔsod2 mutant was transformed
with a multicopy genomic library and PQ resistant transformants
were selected (Materials and Methods). Six transformants showed
a clear co-segregation between plasmid and PQ resistance. The
inserts of the six isolated plasmids were sequenced. Four plasmids
contained a segment of chromosome VIII that included SOD2. One
plasmid had a fragment of chromosome XIII that included two
partial genes and the complete AIM32 gene. One plasmid had a
fragment of chromosome XI including two partial genes, the ar-
ginine t-RNA and seven other genes (RPS27A, RSM22, SRP102,
GPM1, YKL151C, MCR1, and DBR1). Amongst these genes, MCR1
seemed the most likely candidate as it encodes the mitochondrial
NADH-cytochrome b5 reductase. In order to verify that the sup-
pression of PQ sensitivity resulted from overexpression of MCR1,
the gene with its own promoter was cloned into a multicopy
plasmid (Materials and Methods) and used to transform Δsod2. As
a control, the SOD2 gene with its own promoter was also cloned in
a multicopy plasmid and used to transform Δsod2.
As shown in Fig. 2, the overexpression of SOD2 and AIM32
suppressed the inhibitory effect of PQ on Δsod2 cells, both in
YPEth and YPG. The overexpression of MCR1 resulted in a partial
suppression of PQ sensitivity, more clearly observed in YPG.
We also tested if SOD1 overexpression could suppress the PQ
susceptibility of Δsod2 cells. As previously reported [27], increased
Sod1 activity can only be obtained if Ccs1, the chaperone that re-
cruits copper to Sod1, is also expressed at higher level. Therefore,
the Δsod2 mutant was transformed with two multicopy vectors,
one containing SOD1 and the second containing CCS1 (also named
LYS7). The overexpression of SOD1 and its cofactor did not sup-
press PQ susceptibility of the Δsod2 mutant (data not shown).
We sought to check whether the PQ sensitivity of the wt strain
CWWT (see Fig. 1A) could be rescued by the overexpression of
SOD2 or AIM32. However, overexpression of SOD2 had a deleter-
ious effect on the respiratory growth of CWWT (in the absence of
PQ) as the growth yield of the transformed strain reached only 25%
of the growth yield of the control strain. Analysis of the SOD2
overexpressing strain was not pursued further. The overexpression
of AIM32 had no effect on the respiratory growth and PQ sensi-
tivity of CWWT. At 2 mM PQ, the growth yield, monitored as de-
scribed in Fig. 1A, reached 10–15% of the control yield. It seems
therefore that Aim32 confers protection only in Sod2-deﬁcient
cells. By comparison, we tested the effect of NAC on the PQ sen-
sitivity of CWWT. The strain was grown in YPEth with 5 mM NAC
(as in Fig. 2) with or without 2 mM PQ. Addition of NAC partly
rescued the PQ sensitivity as the growth yield reached 45% of the
untreated growth yield, while it reached 12% in absence of NAC.
It would have been interesting to check whether over-
expression of SOD2, AIM32 orMCR1 could rescue the PQ sensitivity
of Δsod1 cells in respiratory medium. However overexpression of
these genes had a deleterious impact onΔsod1 respiratory growth
(in the absence of PQ), precluding the test.
The impact of deleting AIM32 and MCR1 on PQ sensitivity was
tested. The respiratory growth of Δaim32 and Δmcr1 mutants in
YPEth and YPG was not more sensitive to PQ than that of the wild
type (i.e. SOD2), so deletion of these genes did not affect wild-type
PQ sensitivity.
Thus, by searching for multicopy suppressors of Δsod2 sensi-
tivity to PQ, two genes were identiﬁed; AIM32 andMCR1. Mcr1 is a
NADH-cytochrome b5 reductase located in the inter-membrane
space of mitochondria, involved in oxidative stress defence [28–
30]. The function and location of Aim32 are not well deﬁned. Se-
quence analysis showed that the protein is located in themitochondria and contains a thioredoxin-like domain [31,32].
3.4. Primaquine impairs activity of the Fe–S cluster enzyme aconi-
tase in Δsod2 cells
The absence of the mitochondrial Sod2 markedly enhanced PQ
inhibitory action on yeast respiratory growth, which could be
countered by anti-oxidant molecules and by the overexpression of
genes encoding mitochondrial proteins with known or possible
anti-oxidant action.
We thus asked whether PQ treatment could have a detrimental
effect on mitochondrial function.
We ﬁrst checked whether PQ could act as a direct inhibitor of
respiratory function. To that end, the effect of PQ on the oxygen
consumption of intact cells was tested using a Clark-type oxygen
electrode (Materials and Method). Addition of 1 mM PQ in the
assays had no effect on the oxygen uptake activities of Δsod2 and
wt cells. It thus appears that PQ did not act as an inhibitor of the
respiratory function.
We also checked whether more prolonged treatment to PQ
could impair the overall respiratory function of cells. Δsod2 and
wt cells were grown in YPGal with or without 1 mM PQ for 24 h.
The cells were then harvested and their oxygen consumption ac-
tivities were directly monitored (Materials and Methods). The
activities were unaltered by PQ exposure (Table S2). Thus pro-
longed treatment with 1 mM PQ had no signiﬁcant deleterious
effect on the overall oxygen consumption of Δsod2 whereas its
growth yield was decreased by 50% in YPGal and by 90% in YPEth
(Fig. 1C).
In parallel, we tested whether PQ treatment might result in the
loss of mtDNA, and thus increase the production of rho° cells.
Δsod2 cells were cultured in YPGal with 1 mM PQ and the pro-
duction of rho° cells was assessed as described in the Materials and
Methods. The treatment had no effect. Thus at the doses tested, PQ
did not appear to alter mtDNA stability.
We then tested the effect of PQ treatment on aconitase activity
as the TCA cycle enzyme, located in the mitochondrial matrix is
known to be highly sensitive to oxidative damage. As a control, the
activity of the mitochondrial enzyme fumarase, that is not sensi-
tive to oxidative damage, was also monitored. Wt and Δsod2 cells
were cultured for 24 h in YPGal in the absence or in presence of
0.3 or 1 mM PQ. Aconitase and fumarase activities were monitored
as described in Materials and Methods.
Under basal conditions (no PQ treatment), aconitase activity
was decreased about 1.5 fold in Δsod2 compared to wt cell ex-
tracts, whereas the fumarase activity was similar in wt and Δsod2.
After PQ treatment, the aconitase and fumarase activities of wt
were not altered compared to untreated wt controls. By contrast,
the aconitase activity of Δsod2 was further decreased (2.5 fold for
0.3 mM PQ and 4.5 fold for 1 mM PQ) compared to wt while the
fumarase activity remained unchanged. Thus as presented in Fig. 3,
the aconitase/fumarase ratio of 0.65 remained unchanged in the
wt upon PQ treatment whereas in Δsod2 the ratio decreased from
0.35 (untreated) to 0.2 (0.3 mM PQ) and 0.1 (1 mM PQ).
Thus PQ treatment resulted in marked decrease in the activity
of the mitochondrial aconitase that contains ROS-sensitive FeS
cluster. It is most likely that the PQ-induced loss of aconitase ac-
tivity inΔsod2 cells results from the damage of the FeS cluster and
not from the loss of apoprotein because it has been shown that the
apoprotein is required for the maintenance of mtDNA in yeast [33]
and we found that PQ treatment did not increase the production of
rho° cells (cells lacking mtDNA).
By comparison, we tested whether PQ could also impair the
Fig. 3. Effect of primaquine treatment on aconitase activity in cells. Aconitase and
fumarase activities were assessed spectrophotometrically at 240 nm. Total cell
extracts were obtained from a 24 h culture in YPGal with 0, 0.3 or 1 mM PQ (see
Materials and Methods). The reaction was started by addition of the cell extract to
phosphate buffer containing isocitrate as substrate for the aconitase or malate as
substrate for the fumarase. The data are presented as the ratio of the aconitase
activity and the fumarase activity (the individual activities are given in Table S2).
Values represent the averages of at least three measurements, with error bars re-
presenting standard deviation. *, po0.05; and ***, po0.001 according to Mann–
Whitney U test. Wt (blue); Δsod2 (magenta) and Δsod2 overexpression AIM32
(green).
Fig. 4. Effect of primaquine on mitochondrial aconitase activity in vitro. Puriﬁed
mitochondrial aconitase (33 ng mL1) was incubated for 20 min at room tempera-
ture with buffered PQ at different concentrations. The reaction was started by ad-
dition of the cis-aconitate and activity was monitored spectrophotometrically at
240 nm at 37 °C. The activity is expressed as a percentage of the activity obtained
after incubation of the enzyme in the absence of PQ and is the average of four
measurements, with error bars representing standard deviation. **, po0.01 ac-
cording to Mann–Whitney U test.
Fig. 5. Release of Fe from Rli1 during primaquine exposure. Yeast expressing an
HA-tagged construct of Rli1 under tet control were cultured in the absence of
doxycycline to maximise expression. Rli1-HA was immunoprecipitated from pro-
tein extracts of cells preincubated with 55FeCl3. 55Fe release from Rli1 was calcu-
lated from 55Fe determinations after 10 min incubation in vitro with 350 mM as-
corbate/100 mM histidine [25,26] supplemented or not with 10 mM PQ. *, po0.05
according to Student's t-test, two tailed. Data are means from three independent
experiments7SEM.
A. Lalève et al. / Redox Biology 7 (2016) 21–2926activity of two other respiratory enzymes containing Fe-S clusters
that are not readily damaged by oxidative stress: complex III (or
bc1 complex), containing a [2Fe-2S] cluster and complex II (or
succinate dehydrogenase), containing three Fe-S clusters ([2Fe-2S],
[4Fe-4S], and [3Fe-4S]). The Δsod2 cells were grown in the con-
ditions used for the aconitase assay, and measurements of the
enzymatic activities were performed on puriﬁed mitochondria.
Complexes II and III activities were unaffected by 0.3 mM PQ
treatment when compared to untreated controls (Table S2).
We then asked whether the overexpression of AIM32 found to
rescue PQ sensitivity of Δsod2 respiratory growth would protect
the aconitase activity against PQ-induced damage. Δsod2 trans-
formed with the multicopy plasmid carrying AIM32 was cultured
for 24 h in YPGal with or without 1 mM PQ. Aconitase and fu-
marase activities were monitored. As shown in Fig. 3, AIM32
overexpression partly protected aconitase activity against PQ-in-
duced damage. The aconitase/fumarase ratio of PQ treated cells
increased from 0.1 inΔsod2 to 0.2 inΔsod2 overexpressing AIM32.
However, overexpression of AIM32 had no effect on the basal rate
(without PQ treatment), suggesting different roles for Aim32 and
Sod2.
3.5. Primaquine attack on Fe–S containing enzymes in vitro
It has been shown PQ is transformed into several metabolites
mainly by the cytochrome P450 (CYP450) 2D6 and by the mono-
amine oxidase A in mammalian cells [11]. Yeast cells do not have a
monoamine oxidase A. They have two CYP450 enzymes but none
is equivalent to the enzymes involved in PQ metabolism in hu-
mans. Thus PQ is likely to be the active molecule causing growth
defects and decreased aconitase activity in treated yeast cells.
We thus checked whether PQ could damage puriﬁed aconitase
in vitro and observed that PQ exposure decreased aconitase ac-
tivity in a dose dependent manner (Fig. 4).
As shown in Figs. 3 and 4, PQ impaired aconitase activity both
in vivo (in treated cells) and in vitro (using puriﬁed mitochondrial
aconitase).
As PQ was found to attack Fe–S containing aconitase, we rea-
soned that the drug might also impair other Fe–S cluster containingenzymes sensitive to oxidative damage, for instance, Rli1, a [4Fe-4S]
protein previously shown to be susceptible to oxidant-induced Fe–S
turnover in vitro [25]. Thus we checked whether PQ could disrupt
Rli1 Fe–S clusters in vitro by monitoring the release of Fe. Rli1-HA
A. Lalève et al. / Redox Biology 7 (2016) 21–29 27was immunoprecipitated from cells preincubated with 55FeCl3 and
55Fe release assayed during subsequent incubation with 10 μM PQ.
PQ treatment increased the rate of Fe–S turnover from Rli1 by more
than 50% (Fig. 5).4. Discussion
4.1. Defence mechanism against primaquine attack
In this study we investigated the mode of action of the anti-
malarial drug primaquine (PQ) using yeast as a model. We found
that the deletion of genes encoding the superoxide dismutase,
SOD2 and to a lesser extent SOD1 increased the sensitivity to PQ,
while the deletion of other genes involved in oxidative stress de-
fence were without effect.
Sod2, located in the mitochondrial matrix [34,35], is the main
protection against superoxide produced by the respiratory chain.
Our data indicate that Sod2 plays also a key role in the protection
against PQ. We found no redundancy in the protective effects of
Sod activity, as overexpression of SOD1 did not protect Δsod2 cells
from PQ toxicity. This might be because the two Sods differ in their
cellular location, Sod1 being predominantly cytosolic [36].
In the absence of Sod2, addition of the anti-oxidant compounds
ascorbate or of N-acetyl cysteine (NAC) to the culture or the
overexpression of AIM32 andMCR1 decreased the sensitivity to PQ.
The cell defence mechanisms against ROS include Sods, cata-
lase, peroxidases and antioxidants such as ascorbate. In yeast, er-
ythroascorbate is found instead of ascorbate but may play the
same antioxidant role [28]. Interestingly, Mcr1 is involved in the
regeneration of erythroascorbate when the molecule becomes
oxidised through scavenging free radicals [28]. Mcr1 is also in-
volved in ubiquinone-dependent antioxidant protection [29]. The
enzyme is located in the mitochondrial intermembrane space [30].
Overexpression of MCR1 could speed up the regeneration of ery-
throascorbate and ubiquinone, which would provide higher anti-
oxidant protection and thus protect from PQ toxicity. In human
erythrocytes, the Mcr1 equivalent (NADH-cytochrome b5 re-
ductase or NADH methemoglobin reductase) is essential to reduce
methemoglobin back to haemoglobin and limit its concentration
below toxic levels [37]. PQ produces increased levels of methe-
moglobinemia in patients with deﬁciency in NADH methemoglo-
bin reductase [17]. Although the yeast and erythrocyte cells differ
in many aspects, NADH-cytochrome b5 reductase might provide
protection from PQ toxicity in both cellular systems. In P. falci-
parum parasites, a putative NADH-cytochrome b5 reductase is re-
ported (PF3D7_1367500) with a likely mitochondrial location. It
will be interesting to establish whether this enzyme could have a
role in the PQ sensitivity of malaria parasites.
Aim32, predicted to be located in the mitochondria, contains a
thioredoxin-like ferredoxin family domain [32]. Thioredoxin-like
ferredoxins are a large family of Fe–S proteins with unknown
function [38]. Their thioredoxin fold and ferredoxin domain are
suggestive of a role in redox sensing and electron transfer. They
may function as thiol-based molecular switches by modulating
disulphide bond formation in their target proteins [39,40]. In ab-
sence of Sod2, Aim32 might protect PQ-sensitive Fe–S clusters by
buffering PQ-induced oxidative damage. Proteins with similar
function, albeit poorly conserved sequence, are likely to be present
in humans and in the parasite.
4.2. Primaquine attack on Fe–S clusters
Fe-S clusters are notoriously vulnerable to oxidative damage,
which makes several proteins whose function depends on these
co-factors highly sensitive to ROS and possibly to PQ.The mitochondrial matrix aconitase is a dehydratase catalysing
the reversible interconversion of citrate to isocitrate. The protein's
[4Fe-4S] cluster is ligated by three cysteine residues and water
molecules. This cluster is exposed to solvent, which is key for the
catalytic activity, but makes the cluster easily accessible to oxi-
dants. Superoxide and hydrogen peroxide can readily oxidise this
Fe–S cluster [41]. Upon oxidation, the active [4Fe–4S4] cluster
converts to an inactive [3Fe–4S] form (for review [42]). The ab-
sence of Sod2 (and Sod1) which shields the enzyme from oxidative
damage results in a two-fold decrease in aconitase activity [43].
We found that PQ treatment caused a further and severe loss of
aconitase activity in Δsod2 cells. In addition, PQ exposure of pur-
iﬁed aconitase resulted in decreased activity.
In vitro assays showed also that PQ disrupted the Fe–S cluster of
the [4Fe–4S] containing protein Rli1, known to be ROS-sensitive in
vitro [25].
The data suggested that ROS-labile Fe–S groups may be pri-
mary targets of PQ. In addition to aconitase and Rli1, other ROS-
sensitive Fe–S containing proteins might be affected by PQ treat-
ment, such as Nar1. Rli1 and Nar1 are essential proteins. Rli1 is
required for nuclear export of ribosomal subunits, translation
termination and ribosome recycling [25,44]. Nar1 is involved in
the biosynthesis of cytosolic and nuclear Fe–S proteins, so is re-
quired for the essential activity of Rli1 [45]. PQ-induced damage of
their Fe–S clusters would compromise cell growth.
4.3. Primaquine damage, respiratory function and growth defects
PQ inhibited proliferation when cells relied on respiratory
function while the drug had no or little effect on cells relying on
fermentation.
Respiratory growth requires TCA cycle function, thus aconitase
activity. In Δsod2 cells grown in YPGal with 1 mM PQ, the aconi-
tase activity was 4.5-fold lower than in wt cells. However the
oxygen consumption of cells was unaffected, indicating that the
remaining aconitase activity was sufﬁcient for the respiratory
function. When cells are grown in YPEth, the decrease in aconitase
might reach the threshold and become a limiting factor of cell
respiration and growth.
The PQ-induced decrease in aconitase activity would not –or
not fully -account for the observed growth defect, especially in
YPGal. PQ-induced damage to essential proteins such as Rli1 and
Nar1 would cause a growth defect.
Rli1 and Nar1, however, are required during both fermentative
and respiratory growth. The PQ-induced growth defect was ob-
served only when cells relied on respiration. For instance, rho°
mutants that lack the mtDNA and therefore the respiratory chain,
derived from the control strain CWWT and from mutants Δsod2
and Δsod1, were unaffected by PQ treatment. This indicates that
respiratory activity enhances the deleterious effect of PQ. The re-
spiratory chain is generally the major source of endogenous ROS. It
can be hypothesised that the damage to Fe–S clusters results from
the combined action of PQ and ROS produced by the respiratory
chain-and overproduced in absence of Sod2.
The oxidative damage would result from the additive detri-
mental effects of respiratory ROS and PQ. It could also be sug-
gested that PQ would react with the endogenous ROS to produce a
more active compound.
4.4. Primaquine attack in the malaria parasite
We found that PQ treatment impaired aconitase activity in
yeast and hypothesized that the drug might alter other FeS con-
taining enzymes. Recent studies in P. falciparum reported that the
TCA cycle while not needed for parasite survival in asexual blood
stages was required for gametocyte and mosquito stages [46,47].
A. Lalève et al. / Redox Biology 7 (2016) 21–2928In addition, during the sexual (gametocyte) stage, the organization
of mitochondria is more complex and enzymes of the TCA cycle
and of the oxidative phosphorylation pathway as well as many
other mitochondrial proteins are up-regulated [48], compared to
the asexual blood stage. Remarkably, using P. falciparum knockout
lines, aconitase (PF3D7_1342100) was found to be essential for
gametocytogenesis [46,47]. The parasite aconitase is likely to be
ROS-sensitive as are the yeast and mammalian enzymes. Inter-
estingly, the parasite fumarase resembles the Fe–S containing
‘class I'-type enzymes found in some Bacteria and Archaea instead
of the superoxide insensitive ‘class II' type enzyme found in yeast
and mammalian cells [49–51]. In addition, fumarase might be re-
quired at all the stages of the parasites life cycle [46]. Both en-
zymes might be sensitive to PQ-induced damage. A severe de-
crease of their activities upon PQ treatment would affect the re-
spiratory activity and thus the ATP supply, but also biosynthetic
pathways such as haem biosynthesis and pyrimidine synthesis,
and halt parasite development.
It is interesting to note that PQ exerts its toxic effect across
diverse eukaryotic cells when compromised for antioxidant de-
fence, such as erythrocytes with deﬁciencies in G6PD or methe-
moglobin reductase and inΔsod2 yeast. It is tempting to speculate
that Plasmodium parasite stages that are exquisitely sensitive to PQ
might have constitutively weak antioxidant defences and/or oxi-
dative pathways that are highly activated. Plasmodium sp. pos-
sesses several oxidative stress defence enzymes [52], which in-
clude a cytosolic SOD1 (PF3D7_0814900) and a mitochondrial
SOD2 (PF3D7_0623500). However, whereas eukaryotes usually
possess cytosolic Cu/Zn-SOD and mitochondrial Mn-SODs, most of
the protozoan parasites contain only Fe-SODs [53], and the P. fal-
ciparum Fe-SOD enzyme was found to be sensitive to oxidative
inactivation [54]. Therefore, a plausible hypothesis is that exposure
to PQ and its metabolites would cause oxidative damage to the Fe-
SODs of the parasite and overwhelm its antioxidant defence sys-
tem, which then would not be able to shield the aconitase and
maybe other redox-sensitive enzymes. That could result in oxi-
dative killing of the parasites, especially at stages requiring fully
active mitochondria such as gametocytes. Regarding the metabo-
lism of hepatic quiescent forms of P. vivax and P. ovale, little is
known except that these forms are cleared in vitro and in vivo by
PQ. It has been reported that addition of interleukin inhibited the
development of the rodent malaria P. yoelii hepatic cultures and
that the inhibition was the result of an oxidative burst [55], in-
dicating that the parasites at the hepatic stage might be suscep-
tible to oxidative damage.5. Conclusions
We have used the yeast S. cerevisiaemodel to uncover the mode
of action of primaquine (PQ). We observed that yeast sensitivity to
PQ: 1) was markedly increased in a genetic knockout strain that
lacks the gene SOD2 encoding the mitochondrial superoxide dis-
mutase, 2) was restricted to cells relying on the respiratory func-
tion to proliferate, and 3) in absence of Sod2, could be suppressed
by the overexpression of two mitochondrial enzymes involved in
the response to oxidative stress, Aim32 and Mcr1. This indicated a
role for respiratory function – more speciﬁcally for ROS produced
by the respiratory chain-in PQ sensitivity.
We found that PQ treatment impaired the activity of aconitase
and damaged its Fe–S cluster. The Fe–S cluster of the essential
protein Rli1 was also found to be susceptible to PQ attack in vitro,
which leads to the hypothesis that ROS-labile Fe–S clusters would
be primary targets of PQ.
In the malaria parasite, PQ treatment might also damage the
Fe–S cluster of aconitase that is essential for parasite developmentat certain stages of its life cycle. Interestingly, in the parasite, the
mitochondrial fumarase, likely to be an essential enzyme, is also a
Fe–S containing enzyme and is possibly ROS-sensitive. In addition,
the SODs –especially the mitochondrial SOD2- that could shield
the Fe–S groups of these proteins against PQ-induced damage
might be prone to oxidative inactivation. The link between PQ
susceptibility and these mitochondrial enzymes should now also
be investigated in the malaria parasites.Acknowledgement
The study was supported by funding from the Fondation pour
la Recherche Médicale, DPM2012125558 (to AL, JC and BM) and
the BBSRC, BB/I000852/1 (to SA).Appendix A. Supplementary material
Supplementary data associated with this article can be found in
the online version at http://dx.doi.org/10.1016/j.redox.2015.10.008.References
[1] L.H. Miller, H.C. Ackerman, X. Su, T.E. Wellems, Malaria biology and disease
pathogenesis: insights for new treatments, Nat. Med. 19 (2013) 156–167, http:
//dx.doi.org/10.1038/nm.3073.
[2] N. Vale, R. Moreira, P. Gomes, Primaquine revisited six decades after its dis-
covery, Eur. J. Med. Chem. 44 (2009) 937–953, http://dx.doi.org/10.1016/j.
ejmech.2008.08.011.
[3] L. Dembele, A. Gego, A.M. Zeeman, J.F. Franetich, O. Silvie, A. Rametti, et al.,
Towards an in vitro model of Plasmodium hypnozoites suitable for drug dis-
covery, Plos One 6 (2011) e18162, http://dx.doi.org/10.1371/journal.
pone.0018162.
[4] T. Bousema, L. Okell, S. Shekalaghe, J.T. Grifﬁn, S. Omar, P. Sawa, et al., Re-
visiting the circulation time of Plasmodium falciparum gametocytes: molecular
detection methods to estimate the duration of gametocyte carriage and the
effect of gametocytocidal drugs, Malar. J. 9 (2010) 136, http://dx.doi.org/
10.1186/1475-2875-9-136.
[5] S. Shekalaghe, C. Drakeley, R. Gosling, A. Ndaro, M. van Meegeren, A. Enevold,
et al., Primaquine clears submicroscopic Plasmodium falciparum gametocytes
that persist after treatment with sulphadoxine-pyrimethamine and artesu-
nate, Plos One 2 (2007) e1023, http://dx.doi.org/10.1371/journal.
pone.0001023.
[6] M. Delves, D. Plouffe, C. Scheurer, S. Meister, S. Wittlin, E. a Winzeler, et al.,
The activities of current antimalarial drugs on the life cycle stages of Plas-
modium: A comparative study with human and rodent parasites, Plos Med. 9
(2012) e1001169, http://dx.doi.org/10.1371/journal.pmed.1001169.
[7] R.L. Beaudoin, M. Aikawa, Primaquine-induced changes in morphology of
exoerythrocytic stages of malaria, Science 160 (1968) 1233–1234, http://dx.
doi.org/10.1126/science.160.3833.1233.
[8] R. Howells, W. Pters, J. Fullard, Fine structural changes observed in the er-
yhrocytic stages of Plasmodium berghei berghei following exposure to prima-
quine and menoctone, Ann. Trop. Med. Parasitol. 64 (1970) 203–207.
[9] Y. Boulard, I. Landau, F. Miltgen, D.S. Ellis, W. Peters, Ultrastructural changes
induced in exo-erythrocytic schizonts of Plasmodium yoelii yoelii by prima-
quine, Ann. Trop. Med. Parasitol. 77 (1983) 555–568.
[10] H. Lanners, Effect of the 8-aminoquinoline primaquine on culture-derived
gametocytes of the malaria parasite Plasmodium falciparum, Parasitol. Res. 77
(1991) 478–481.
[11] B.S. Pybus, J.C. Sousa, X. Jin, J.A. Ferguson, R.E. Christian, R. Barnhart, et al.,
CYP450 phenotyping and accurate mass identiﬁcation of metabolites of the
8-aminoquinoline, anti-malarial drug primaquine, Malar. J. 11 (2012) 259,
http://dx.doi.org/10.1186/1475-2875-11-259.
[12] B.S. Pybus, S.R. Marcsisin, X. Jin, G. Deye, J.C. Sousa, Q. Li, et al., The metabolism
of primaquine to its active metabolite is dependent on CYP 2D6, Malar. J. 12
(2013) 212, http://dx.doi.org/10.1186/1475-2875-12-212.
[13] B.M.J. Potter, L.H. Xie, C. Vuong, J. Zhang, P. Zhang, D. Duan, et al., Differential
CYP 2D6 metabolism alters primaquine pharmacokinetics, Antimicrob. Agents
Chemother. 59 (2015) 2380–2387, http://dx.doi.org/10.1128/AAC.00015-15.
[14] J. Vasquez-Vivar, O. Augusto, Oxidative activity of primaquine metabolites on
rat erythrocytes in vitro and in vivo, Biochem. Pharmacol. 47 (1994) 309–316,
http://dx.doi.org/10.1016/0006-2952(94)90022-1.
[15] T. Magwere, Y.S. Naik, J.A. Hasler, Primaquine alters antioxidant enzyme pro-
ﬁles in rat liver and kidney, Free. Radic. Res. 27 (1997) 173–179, http://dx.doi.
org/10.3109/10715769709097849.
[16] S. Ganesan, N.D. Chaurasiya, R. Sahu, L.A. Walker, B.L. Tekwani, Understanding
A. Lalève et al. / Redox Biology 7 (2016) 21–29 29the mechanisms for metabolism-linked hemolytic toxicity of primaquine
against glucose 6-phosphate dehydrogenase deﬁcient human erythrocytes:
Evaluation of eryptotic pathway, Toxicology 294 (2012) 54–60, http://dx.doi.
org/10.1016/j.tox.2012.01.015.
[17] R.J. Cohen, J.R. Sachs, D.J. Wicker, M.E. Conrad, Methemoglobinemia provoked
by malarial chemoprophylaxis in Vietnam, N Engl. J. Med. 279 (1968)
1127–1131, http://dx.doi.org/10.1056/NEJM196811212792102.
[18] WHO, Glucose-6-phosphate dehydrogenase deﬁciency, Bull World Heal, Organ
67 (1989) 601–611.
[19] N. Bonneaud, O. Ozier-Kalogeropoulos, G.Y. Li, M. Labouesse, L. Minvielle-Se-
bastia, F. Lacroute, A family of low and high copy replicative, integrative and
single-stranded S. cerevisiae/E. coli shuttle vectors, Yeast 7 (1991) 609–615,
http://dx.doi.org/10.1002/yea.320070609.
[20] H.A. Krebs, O. Holzach, The conversion of citrate into cis-aconitate and iso-
citrate in the presence of aconitase, Biochem. J. 52 (1952) 527–528.
[21] M. Patel, B.J. Day, J.D. Crapo, I. Fridovich, J.O. McNamara, Requirement for
superoxide in excitotoxic cell death, Neuron 16 (1996) 345–355, http://dx.doi.
org/10.1016/S0896-6273(00)80052-5.
[22] E. Racker, Spectrophotometric measurements of the enzymatic formation of
fumaric and cis-aconitic acids, Biochim. Biophys. Acta 4 (1950) 211–214, http:
//dx.doi.org/10.1016/0006-3002(50)90026-6.
[23] M.A. Wallace, S. Bailey, J.M. Fukuto, J.S. Valentine, E.B. Gralla, Induction of
phenotypes resembling CuZn-superoxide dismutase deletion in wild-type
yeast cells: An in vivo assay for the role of superoxide in the toxicity of redox-
cycling compounds, Chem. Res. Toxicol. 18 (2005) 1279–1286, http://dx.doi.
org/10.1021/tx050050n.
[24] G. Dujardin, C. Lemaire, Preparation of respiratory chain complexes from
Saccharomyces cerevisiae wild-type and mutant mitochondria : activity mea-
surement and subunit composition analysis, Methods Mol. Biol. 432 (2008)
65–81, http://dx.doi.org/10.1007/978-1-59745-028-7_5.
[25] A. Alhebshi, T.C. Sideri, S.L. Holland, S.V. Avery, The essential iron-sulfur pro-
tein Rli1 is an important target accounting for inhibition of cell growth by
reactive oxygen species, Mol. Biol. Cell 23 (2012) 3582–3590, http://dx.doi.
org/10.1091/mbc.E12-05-0413.
[26] L. Macomber, J.A. Imlay, The iron-sulfur clusters of dehydratases are primary
intracellular targets of copper toxicity, Proc. Natl. Acad. Sci. S. A 106 (2009)
8344–8349, http://dx.doi.org/10.1073/pnas.0812808106.
[27] N. Harris, V. Costa, M. MacLean, M. Mollapour, P. Moradas-Ferreira, P.W. Piper,
MnSOD overexpression extends the yeast chronological (G0) life span but acts
independently of Sir2p histone deacetylase to shorten the replicative life span
of dividing cells, Free Radic. Biol. Med. 34 (2003) 1599–1606, http://dx.doi.org/
10.1016/S0891-5849(03)00210-7.
[28] J. Lee, W. Huh, B. Lee, Y. Baek, C. Hwang, S. Kim, et al., Mitochondrial NADH-
cytochrome b5 reductase plays a crucial role in the reduction of D -ery-
throascorbyl free radical in Saccharomyces cerevisiae, Biochim. Biophys. Acta
1527 (2001) 31–38, http://dx.doi.org/10.1016/S0304-4165(01)00134-9.
[29] P. Navas, J.M. Villalba, R. de Cabo, The importance of plasma membrane
coenzyme Q in aging and stress responses, Mitochondrion (7 Suppl) (2007)
S34–S40, http://dx.doi.org/10.1016/j.mito.2007.02.010.
[30] B. Meineke, G. Engl, C. Kemper, A. Vasiljev-Neumeyer, H. Paulitschke,
D. Rapaport, The outer membrane form of the mitochondrial protein Mcr1
follows a TOM-independent membrane insertion pathway, FEBS Lett. 582
(2008) 855–860, http://dx.doi.org/10.1016/j.febslet.2008.02.009.
[31] A. Marchler-Bauer, M.K. Derbyshire, N.R. Gonzales, S. Lu, F. Chitsaz, L.Y. Geer,
et al., CDD: NCBI’s conserved domain database, Nucleic Acids Res. 43, Data
issue (2014) D222–D226, http://dx.doi.org/10.1093/nar/gku1221.
[32] 〈http://pedant.helmoltz-muenchen.de/〉, Entry: Saccharomyces cerevisiae, gene
YML050w. Last accessed 2 october 2015.
[33] X.J. Chen, X. Wang, B.A. Kaufman, R.A. Butow, Aconitase couples metabolic
regulation to mitochondrial DNA maintenance, Science 307 (2005) 714–717,
http://dx.doi.org/10.1126/science.1106391.
[34] R.A. Weisiger, I. Fridovich, Mitochondrial superoxide dismutase. Site of
synthesis and intramitochondrial localization, J. Biol. Chem. 248 (1973)
4793–4796.
[35] S.D. Ravindranath, I. Fridovich, Isolation and characterization of a manganese-containing superoxide dismutase from yeast, J. Biol. Chem. 250 (1975)
6107–6112, http://dx.doi.org/10.1016/0003-9861(78)90027-9.
[36] J.M. McCord, I. Fridovich, Superoxide dismutase. An enzymatic function for
erythrocuprein (hemocuprein), J. Biol. Chem. 244 (1969) 6049–6055.
[37] J. Umbreit, Methemoglobin—It’s Not Just Blue: A Concise Review, Am. J. He-
matol. 82 (2007) 134–144.
[38] J. Meyer, Ferredoxins of the third kind, FEBS Lett. 509 (2001) 1–5, http://dx.
doi.org/10.1016/S0014-5793(01)03049-6.
[39] E.-M. Hanschmann, J.R. Godoy, C. Berndt, C. Hudemann, C.H. Lillig, Thior-
edoxins, glutaredoxins, and peroxiredoxins–molecular mechanisms and
health signiﬁcance: from cofactors to antioxidants to redox signaling, Anti-
oxid. Redox Signal. 19 (2013) 1539–1605, http://dx.doi.org/10.1089/
ars.2012.4599.
[40] B. Groitl, U. Jakob, Thiol-based redox switches, Biochim. Biophys, Acta-Proteins
Proteom. 1844 (2014) 1335–1343, http://dx.doi.org/10.1016/j.
bbapap.2014.03.007.
[41] A. Hausladen, I. Fridovich, Superoxide and peroxynitrite inactivate aconitases,
but nitric oxide does not, J. Biol. Chem. 269 (1994) 29405–29408.
[42] J.A. Imlay, Iron-sulphur clusters and the problem with oxygen, Mol. Microbiol.
59 (2006) 1073–1082, http://dx.doi.org/10.1111/j.1365-2958.2006.05028.x.
[43] J. Strain, C.R. Lorenz, J. Bode, S. Garland, G. a Smolen, D.T. Ta, et al., Suppressors
of superoxide dismutase (SOD1) deﬁciency in Saccharomyces cerevisiae.
Identiﬁcation of proteins predicted to mediate iron-sulfur cluster assembly, J.
Biol. Chem. 273 (1998) 31138–31144, http://dx.doi.org/10.1074/
jbc.273.47.31138.
[44] E. Nürenberg, R. Tampé, Tying up loose ends: Ribosome recycling in eu-
karyotes and archaea, Trends Biochem. Sci. 38 (2013) 64–74, http://dx.doi.org/
10.1016/j.tibs.2012.11.003.
[45] J. Balk, A.J. Pierik, D.J.A. Netz, U. Mühlenhoff, R. Lill, The hydrogenase-like
Nar1p is essential for maturation of cytosolic and nuclear iron-sulphur pro-
teins, EMBO J. 23 (2004) 2105–2115, http://dx.doi.org/10.1038/sj.
emboj.7600216.
[46] H. Ke, I.A. Lewis, J.M. Morrisey, K.J. McLean, S.M. Ganesan, H.J. Painter, et al.,
Genetic investigation of tricarboxylic acid metabolism during the Plasmodium
falciparum life cycle, Cell. Rep. 11 (2015) 164–174, http://dx.doi.org/10.1016/j.
celrep.2015.03.011.
[47] J.I. MacRae, M.W. Dixon, M.K. Dearnley, H.H. Chua, J.M. Chambers, S. Kenny,
et al., Mitochondrial metabolism of sexual and asexual blood stages of the
malaria parasite Plasmodium falciparum, BMC Biol. 11 (2013) 67, http://dx.doi.
org/10.1186/1741-7007-11-67.
[48] N. Hall, M. Karras, J.D. Raine, J.M. Carlton, T.W.A. Kooij, M. Berriman, et al., A
comprehensive survey of the Plasmodium life cycle by genomic, tran-
scriptomic, and proteomic analyses, Science 307 (2005) 82–86, http://dx.doi.
org/10.1126/science.1103717.
[49] G.G. Van Dooren, L.M. Stimmler, G.I. McFadden, Metabolic maps and functions
of the Plasmodium mitochondrion, FEMS Microbiol. Rev. 30 (2006) 596–630,
http://dx.doi.org/10.1111/j.1574-6976.2006.00027.x.
[50] S.A. Woods, S.D. Schwartzbach, J.R. Guest, Two biochemically distinct classes
of fumarase in Escherichia coli, Biochim. Biophys. Acta 954 (1988) 14–26, http:
//dx.doi.org/10.1016/0167-4838(88)90050-7.
[51] D.H. Flint, M.H. Emptage, J.R. Guest, Fumarase A from Escherichia coli: Pur-
iﬁcation and characterization as an iron-sulfur cluster containing enzyme,
Biochemistry 31 (1992) 10331–10337, http://dx.doi.org/10.1021/bi00157a022.
[52] S. Müller, Redox and antioxidant systems of the malaria parasite Plasmodium
falciparum, Mol. Microbiol. 53 (2004) 1291–1305, http://dx.doi.org/10.1111/
j.1365-2958.2004.04257.x.
[53] I. Fridovich, Superoxide radical and superoxide dismutases, Annu. Rev. Bio-
chem. 64 (1995) 97–112, http://dx.doi.org/10.1146/annurev.biochem.64.1.97.
[54] S. Gratepanche, S. Ménage, D. Touati, R. Wintjens, P. Delplace, M. Fontecave,
et al., Biochemical and electron paramagnetic resonance study of the iron
superoxide dismutase from Plasmodium falciparum, Mol. Biochem. Parasitol.
120 (2002) 237–246, http://dx.doi.org/10.1016/S0166-6851(02)00004-X.
[55] S. Pied, L. Rénia, A. Nüssler, F. Miltgen, D. Mazier, Inhibitory activity of IL-6 on
malaria hepatic stages, Parasite Immunol. 13 (1991) 211–217, http://dx.doi.
org/10.1111/j.1365-3024.1991.tb00276.x.
